Morgan Stanley set a price objective on LiveRamp, while Boston Partners simultaneously lifted its holdings in the company.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley set a price objective on LiveRamp, while Boston Partners simultaneously lifted its holdings in the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
LiveRamp
San Francisco, California-based SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
- LiveRamp, Databricks, DoorDash, Adobe, and OpenAI have formed a partnership focused on agentic customer data platforms, commerce pipelines, and advertising tools.
- Clear Channel Outdoor, TransUnion, and LiveRamp announced a partnership focused on data platform expansion and integrations with marketing mix modeling solutions.
-
Boston Partners
US investment management corporation
-
Morgan Stanley
U.S. investment bank
Related events
- Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
- Morgan Stanley, Jefferies Financial Group, and Royal Bank of Canada issued rating and price target updates on September 14, 2026.
- HSBC provided a buy rating and price target for Johnson & Johnson, while Morgan Stanley raised its price objective to $294.00. The company also filed required 13F reports with the SEC.
- Morgan Stanley decreased its price objective on MercadoLibre, while Norges Bank and Capital Research Global Investors increased their stakes.
- Morgan Stanley raised price objectives on Cisco, while a lawsuit alleged the company helped China persecute Falun Gong. HSBC also issued a research report.